Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance

Journal of Lipid Research

Volumn 55, Issue 1, 2014, Pages 128-137

  Couture, Patrick ^a,b   Tremblay, André J ^a,b   Kelly, Isabelle ^c   Lemelin, Valéry ^d   Droit, Arnaud ^c   Lamarche, Benoit ^a  

^a Lipid Research Centre   (Canada)

^b Proteomic Center   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

Author keywords

Apolipoprotein B 100; Apolipoprotein B 48; Cholesterol; Fatty acids; Intestine; Kinetic

Indexed keywords

APOLIPOPROTEIN B; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INSULIN; LEUCINE; LIPOPROTEIN; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; TRIGLYCERIDE RICH LIPOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; DUODENUM BIOPSY; DYSLIPIDEMIA; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; KEY INTESTINAL GENE; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIPOPROTEIN SYNTHESIS; MALE; METABOLIC REGULATION; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WAIST CIRCUMFERENCE; YOUNG ADULT;

APOLIPOPROTEIN B-100; APOLIPOPROTEIN B-48; CHOLESTEROL; FATTY ACIDS; INTESTINE; KINETIC;

ADULT; APOLIPOPROTEIN B-100; APOLIPOPROTEIN B-48; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DOWN-REGULATION; DUODENUM; DYSLIPIDEMIAS; FATTY ACIDS, NONESTERIFIED; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; KINETICS; LIPID METABOLISM; MALE; MIDDLE AGED; TRANSCRIPTOME; TRIGLYCERIDES; YOUNG ADULT;

EID: 84891349027     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M040071     Document Type: Article

References (43)

1. Ginsberg , H. N. 2000 . Insulin resistance and cardiovascular disease. J. Clin. Invest. 106 : 453-458 .
2. Duez , H. , B. Lamarche , K. D. Uffelman , R. Valero , J. S. Cohn , and G. F. Lewis . 2006 . Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48- containing lipoproteins in humans. Arterioscler. Thromb. Vasc. Biol. 26 : 1357-1363 .
3. Duez , H. , B. Lamarche , R. Valero , M. Pavlic , S. Proctor , C. Xiao , L. Szeto , B. W. Patterson , and G. F. Lewis . 2008 . Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans. Circulation . 117 : 2369-2376 .
4. Duvillard , L. , F. Pont , E. Florentin , C. Galland-Jos , P. Gambert , and B. Verges . 2000 . Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study. Eur. J. Clin. Invest. 30 : 685-694 .
5. Ginsberg , H. N. 1987 . Very low density lipoprotein metabolism in diabetes mellitus. Diabetes Metab. Rev. 3 : 571-589 .
6. Hogue , J. C. , B. Lamarche , A. J. Tremblay , J. Bergeron , C. Gagné , and P. Couture . 2007 . Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. J. Lipid Res. 48 : 1336-1342 .
7. McNamara , J. R. , P. K. Shah , K. Nakajima , L. A. Cupples , P. W. Wilson , J. M. Ordovas , and E. J. Schaefer . 2001 . Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis . 154 : 229-236 .
8. Mero , N. , M. Syvanne , B. Eliasson , U. Smith , and M. R. Taskinen . 1997 . Postprandial elevation of ApoB-48-containing triglyceriderich particles and retinyl esters in normolipemic males who smoke. Arterioscler. Thromb. Vasc. Biol. 17 : 2096-2102 .
9. Kolovou , G. D. , K. K. Anagnostopoulou , S. S. Daskalopoulou , D. P. Mikhailidis , and D. V. Cokkinos . 2005 . Clinical relevance of postprandial lipaemia. Curr. Med. Chem. 12 : 1931-1945 .
10. Adeli , K. , and G. F. Lewis . 2008 . Intestinal lipoprotein overproduction in insulin-resistant states. Curr. Opin. Lipidol. 19 : 221-228 .
11. Levy , E. , S. Spahis , E. Ziv , A. Marette , M. Elchebly , M. Lambert , and E. Delvin . 2006 . Overproduction of intestinal lipoprotein containing apolipoprotein B-48 in Psammomys obesus: impact of dietary n-3 fatty acids. Diabetologia . 49 : 1937-1945 .
12. Lally , S. , D. Owens , and G. H. Tomkin . 2007 . Genes that affect cholesterol synthesis, cholesterol absorption, and chylomicron assembly: the relationship between the liver and intestine in control and streptozotosin diabetic rats. Metabolism . 56 : 430-438 .
13. Lally , S. , D. Owens , and G. H. Tomkin . 2007 . The different effect of pioglitazone as compared to insulin on expression of hepatic and intestinal genes regulating post-prandial lipoproteins in diabetes. Atherosclerosis . 193 : 343-351 .
14. Harris , J. , and F. Benedict . 1919 . A Biometric Study of Basal Metabolism in Man. Carnegie Institution, Washington, DC.
15. Havel , R. J. , H. Eder , and J. Bragdon . 1955 . The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34 : 1345-1353 .
16. Albers , J. J. , G. R. Warnick , D. Wiebe , P. King , P. Steiner , L. Smith , C. Breckenridge , A. Chow , K. Kuba , S. Weidman , et al . 1978 . Multilaboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin. Chem. 24 : 853-856 .
17. Matthan , N. R. , A. Giovanni , E. J. Schaefer , B. G. Brown , and A. H. Lichtenstein . 2003 . Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL. J. Lipid Res. 44 : 800-806 .
18. Desbuquois , B. , and G. D. Aurbach . 1971 . Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J. Clin. Endocrinol. Metab. 33 : 732-738 .
19. Richterich , R. , and H. Dauwalder . 1971 . Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method. Schweiz. Med. Wochenschr. 101 : 615-618 .
20. Heding , L. G. 1975 . Radioimmunological determination of human C-peptide in serum. Diabetologia . 11 : 541-548 .
21. Vilsboll , T. , T. Krarup , J. Sonne , S. Madsbad , A. Volund , A. G. Juul , and J. J. Holst . 2003 . Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 88 : 2706-2713 .
22. Matthews , D. R. , J. P. Hosker , A. S. Rudenski , B. A. Naylor , D. F. Treacher , and R. C. Turner . 1985 . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia . 28 : 412-419 .
23. Kotite , L. , N. Bergeron , and R. J. Havel . 1995 . Quantifi cation of apolipoproteins B-100, B-48, and E in human triglyceride-rich lipoproteins. J. Lipid Res. 36 : 890-900 .
24. Welty , F. K. , A. H. Lichtenstein , P. H. Barrett , G. G. Dolnikowski , and E. J. Schaefer . 1999 . Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes. Arterioscler. Thromb. Vasc. Biol. 19 : 2966-2974 .
25. Dwyer , K. P. , P. H. Barrett , D. Chan , J. I. Foo , G. F. Watts , and K. D. Croft . 2002 . Oxazolinone derivative of leucine for GC-MS: a sensitive and robust method for stable isotope kinetic studies of lipoproteins. J. Lipid Res. 43 : 344-349 .
26. Cobelli , C. , G. Toffolo , D. M. Bier , and R. Nosadini . 1987 . Models to interpret kinetic data in stable isotope tracer studies. Am. J. Physiol. 253 : E551-E564 .
27. Tremblay , A. J. , B. Lamarche , J. C. Hogue , and P. Couture . 2009 . Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia. J. Lipid Res. 50 : 1463-1471 .
28. Tremblay , A. J. , B. Lamarche , V. Guay , A. Charest , V. Lemelin , and P. Couture . 2013 . Short-term, high-fat diet increases the expression of key intestinal genes involved in lipoprotein metabolism in healthy men. Am. J. Clin. Nutr. 98 : 32-41 .
29. Altmann , S. W. , H. R. Davis , Jr ., L. J. Zhu , X. Yao , L. M. Hoos , G. Tetzloff , S. P. Iyer , M. Maguire , A. Golovko , M. Zeng , et al . 2004 . Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science . 303 : 1201-1204 .
30. Haidari , M. , N. Leung , F. Mahbub , K. D. Uffelman , R. Kohen- Avramoglu , G. F. Lewis , and K. Adeli . 2002 . Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J. Biol. Chem. 277 : 31646-31655 .
31. Zoltowska , M. , E. Ziv , E. Delvin , M. Lambert , E. Seidman , and E. Levy . 2004 . Both insulin resistance and diabetes in Psammomys obesus upregulate the hepatic machinery involved in intracellular VLDL assembly. Arterioscler. Thromb. Vasc. Biol. 24 : 118-123 .
32. Zoltowska , M. , E. Ziv , E. Delvin , D. Sinnett , R. Kalman , C. Garofalo , E. Seidman , and E. Levy . 2003 . Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes. Diabetes . 52 : 2539-2545 .
33. Vine , D. F. , R. Takechi , J. C. Russell , and S. D. Proctor . 2007 . Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome. Atherosclerosis . 190 : 282-290 .
34. Sasase , T. , H. Morinaga , H. Yamamoto , N. Ogawa , K. Matsui , K. Miyajima , T. Kawai , Y. Mera , T. Masuyama , M. Shinohara , et al . 2007 . Increased fat absorption and impaired fat clearance cause postprandial hypertriglyceridemia in spontaneously diabetic Torii rat. Diabetes Res. Clin. Pract. 78 : 8-15 .
35. Tremblay , A. J. , B. Lamarche , V. Lemelin , L. Hoos , S. Benjannet , N. G. Seidah , H. R. Davis , Jr ., and P. Couture . 2011 . Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men. J. Lipid Res. 52 : 558-565 .
36. Veilleux , A. , E. Grenier , A. Carpentier , A. Richard , and E. Levy . 2012 . Alteration in intestinal insulin signaling in obese subjects and their effect on lipid and lipoprotein metabolism. Diabetes . 61 (Suppl. 1): A15 .
37. Phillips , C. , K. Mullan , D. Owens , and G. H. Tomkin . 2006 . Intestinal microsomal triglyceride transfer protein in type 2 diabetic and nondiabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition. Atherosclerosis . 187 : 57-64 .
38. Hagan , D. L. , B. Kienzle , H. Jamil , and N. Hariharan . 1994 . Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes. Cell type-specifi c expression and response to metabolic regulators. J. Biol. Chem. 269 : 28737-28744 .
39. Lin , M. C. , D. Gordon , and J. R. Wetterau . 1995 . Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J. Lipid Res. 36 : 1073-1081 .
40. Pavlic , M. , C. Xiao , L. Szeto , B. W. Patterson , and G. F. Lewis . 2010 . Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids. Diabetes . 59 : 580-587 .
41. Ota , T. , C. Gayet , and H. N. Ginsberg . 2008 . Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J. Clin. Invest. 118 : 316-332 .
42. Brown , M. S. , and J. L. Goldstein . 1997 . The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membranebound transcription factor. Cell . 89 : 331-340 .
43. Horton , J. D. , J. L. Goldstein , and M. S. Brown . 2002 . SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109 : 1125-1131